Skip to content

The Evaluation Study of the Effectiveness of Symptom Cluster Monitoring and Intervention Strategies Among Patients with Head and Neck Cancer(HNC) Undergoing Radiotherapy and/or Chemotherapy

The Evaluation Study of the Effectiveness of Symptom Cluster Monitoring and Intervention Strategies Among Patients with Head and Neck Cancer(HNC) Undergoing Radiotherapy and/or Chemotherapy

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400086495
Enrollment
Unknown
Registered
2024-07-03
Start date
2024-07-03
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and Neck Cancer

Interventions

Conventional group:Conventional symptom management strategies are adopted, and targeted interventions are given when patients have symptoms
Control group (pre-rehabilitation group):? Gastrointestinal symptoms: TCM acupuncture intervention, the use of nutritional composition instruments, precise formulation of nutritional recipes ? Pain sy
Instruct patients to use the correct mouthwash, oral spray
Traditional Chinese medicine conditioning, produce fluid to relieve thirst and relieve symptoms. ? Muscle fibrosis: neck muscle relaxation training exercise ? Skin symptoms (including oral mucositis,
Self-made oral exercises, preventive rehabilitation training
Prophylactic use of medical radiation protectants.

Sponsors

Fujian Medical University Union Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Age: =18 years old; (2) Patients who meet the diagnostic criteria of the Chinese Society of Clinical Oncology (CSCO) Guidelines for the Diagnosis and Treatment of Head and Neck Tumors (2021) and are diagnosed with head and neck malignant tumors for the first time ; (3) Chemotherapy/targeted therapy and radiation therapy are required; (4) No previous mental illness, can actively cooperate with the investigation; (5) Obtain informed consent and voluntarily participate in this survey.

Exclusion criteria

Exclusion criteria: (1) HNC tumor recurrence patients; (2) Combined with other malignant tumors; (3) Language communication barriers, unable to cooperate with the investigation of patients; (4) Failure to complete the course of treatment for other reasons (interruption of treatment).

Design outcomes

Primary

MeasureTime frame
QLQ-C30;Karnofsky;Nutrition Risk Screening,NRS2002;Cancer Fatigue Scale, CFS;DMSM;

Secondary

MeasureTime frame
numeric rating scale, NRS;

Countries

China

Contacts

Public ContactBihua Lin

Fujian Medical University Union Hospital

55887423@qq.com+86 137 9932 5903

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026